Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Insulet (PODD) Shares Outstanding (2016 - 2026)

Insulet filings provide 16 years of Shares Outstanding readings, the most recent being $70.4 million for Q4 2025.

On a quarterly basis, Shares Outstanding changed 0.28% to $70.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $70.4 million, a 0.28% change, with the full-year FY2025 number at $70.4 million, changed 0.28% from a year prior.
Shares Outstanding hit $70.4 million in Q4 2025 for Insulet, roughly flat from $70.3 million in the prior quarter.
In the past five years, Shares Outstanding ranged from a high of $70.4 million in Q2 2025 to a low of $66.2 million in Q1 2021.
Median Shares Outstanding over the past 5 years was $69.8 million (2023), compared with a mean of $69.6 million.
Biggest five-year swings in Shares Outstanding: grew 5.0% in 2021 and later increased 0.28% in 2025.
Insulet's Shares Outstanding stood at $69.2 million in 2021, then grew by 0.48% to $69.5 million in 2022, then increased by 0.57% to $69.9 million in 2023, then increased by 0.41% to $70.2 million in 2024, then rose by 0.28% to $70.4 million in 2025.
The last three reported values for Shares Outstanding were $70.4 million (Q4 2025), $70.3 million (Q3 2025), and $70.5 million (Q2 2025) per Business Quant data.